Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma

Mayuresh Naik1 Department of Ophthalmology, H.I.M.S.R & H.A.H. Centenary Hospital, New Delhi, IndiaCorrespondence[email protected]

Monika Kapur2 Department of Ophthalmology, School of Medical Sciences & Research, Sharda University, Greater Noid, Uttar Pradesh, IndiaView further author information

VishnuSwarup Gupta1 Department of Ophthalmology, H.I.M.S.R & H.A.H. Centenary Hospital, New Delhi, IndiaView further author information

HarinderSingh Sethi3 Department of Ophthalmology, V.M.M.C & Safdarjung Hospital, New Delhi, 110029, IndiaView further author information

Kartikeya Srivastava3 Department of Ophthalmology, V.M.M.C & Safdarjung Hospital, New Delhi, 110029, IndiaView further author information

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.